SecBot SecBot

VCEL

Vericel Corp
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. MI· CIK 0000887359 Biotech & Drug Discovery
$57.48 +0.52 (+0.91%)
Nov 16 4:00 PM ET · prev $56.96
Market cap
$2.9B
Mid cap
Consensus
Buy
86% Buy or better · 14 analysts
Median target
$64.00
+11% · range $60.00–75.00
1 year
+45.8%
from $39.43 · Nov 17
30 days
+42.4%
from $40.37
52-week range
$29.34–59.45
−3% from high · low Mar 27
Avg volume 20D
942.0K
Nov 5 spike 2.68M
Short interest
5.36M
≈10.5% of shares · +2.4%
Days to cover
9.8
at average volume
Insider net
−$9.2M
0 buyers · 7 sellers · since Jun 2
New fund stakes
1
Q3 2026 13F · 2 exits
Filing reports
30
analyzed by SecBot
SecBot read BULLISH 18 reports · 90 days
Balance 0 bearish · 2 bullish · 16 neutral oldest → newest, height = score
Avg score ·High conf. 16/18

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    7 insiders sold $9.2M.

  • InstitutionsBULLISH

    Q3 2026: 34 added (1 new), 8 trimmed or exited. Largest new: Qube Research & Technologies $15.6M.

  • AnalystsBULLISH

    12 of 14 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate $0.534 → $0.558 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest +2.4% to 5.36M shares. 9.8 days to cover, ≈10.5% of shares.

  • TrendUPTREND

    33% above its 50-day average. New closing high $59.45 on Nov 11.

Who's buying

13F· Q3 2026
1
new positions
2
exits
$15.6M
in new stakes
FundMoveSharesValue
Aberdeen Group plcDOUBLED2,164,250$99.3M
MORGAN STANLEYADD552,203$22.2M
Invesco Ltd.ADD402,722$16.2M
Qube Research & Technologies LtdNEW388,384$15.6M
PRINCIPAL FINANCIAL GROUP INCADD335,424$13.5M
PUBLIC SECTOR PENSION INVESTMENT BOARDADD312,194$12.6M
FEDERATED HERMES, INC.ADD301,207$12.1M
FIRST TRUST ADVISORS LPDOUBLED182,013$7.3M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

14 analysts
Buy 86% rate it Buy or better
Strong Buy5Buy7Hold2Sell0Strong Sell0
12-month targets · 7 analysts

Price is below the lowest target. Median implies +11%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 10, 2026Stephens & Co.
MAINTAIN
MAINTAINOverweight
Nov 9, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Nov 6, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Oct 14, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Jul 31, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Jul 31, 2026Truist Securities
REITERATE
REITERATEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$9.2M
sold · 7 insiders
DateInsiderTypeValue
Nov 11, 2026
Mara Joseph Anthony Jr
Chief Financial Officer
Nov 11, 2026
EXERCISE$349.04
Nov 11, 2026
Mara Joseph Anthony Jr
Chief Financial Officer
Nov 11, 2026
SELL$478.00
Nov 10, 2026
MCLAUGHLIN KEVIN F
Director
Nov 10, 2026
SELL$412.7K
Nov 10, 2026
MCLAUGHLIN KEVIN F
Director
Nov 10, 2026
EXERCISE$91.3K
Nov 9, 2026
ZERBE ROBERT L MD
Director
Nov 9, 2026
SELL$115.8K
Nov 9, 2026
ZERBE ROBERT L MD
Director
Nov 9, 2026
EXERCISE$26.1K
Nov 9, 2026
Mara Joseph Anthony Jr
Chief Financial Officer
Nov 9, 2026
EXERCISE$1.1M
Nov 9, 2026
Mara Joseph Anthony Jr
Chief Financial Officer
Nov 9, 2026
SELL$1.5M

Earnings setup

Estimates
$0.56
EPS estimate, this quarter
+4%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.56$0.47–$0.62+4.5%$114.0M
Next Q-$0.03-$0.09–$0.02+55.2%$80.3M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
5,364,126
shares short
+2.4%
vs prior settlement
9.8
days to cover
≈10.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
Jonathan Siegal, an officer of Vericel Corp, filed a Form 144 notice of intent to sell 1,885 shares of common stock…
144 · Impact 2/10
Nov 13, 2026 Other
Vericel to Present at the Stephens Annual Investment Conference on Wednesday, November 18, 2026
BURLINGTON, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in
Nov 12, 2026 SEC
Four Vericel insiders (CFO, CLO, PAO, and a director) sold a total of $1.64M in open-market sales over a 7-day window…
CLUSTER · Impact 3/10
Nov 12, 2026 SEC
Joseph Mara, an officer of Vericel, filed a Form 144 notice of intent to sell 8 shares of common stock (approximate…
144 · Impact 1/10
Nov 11, 2026 Insider
Mara Joseph Anthony Jr acquired via exercise 8 shares
Chief Financial Officer @ $43.63 ($349.04)
Nov 11, 2026 Insider
Mara Joseph Anthony Jr sold 8 shares
Chief Financial Officer @ $59.75 ($478.00)
Nov 10, 2026 Insider
MCLAUGHLIN KEVIN F sold 7,000 shares
Director @ $58.96 ($412.7K)
Sep 30, 2026 Inst.
Aberdeen Group plc · DOUBLED
2,164,250 shares ($99.3M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

30 filings · 6 bullish · 0 bearish · 24 neutral
All VCEL filing & press-release reports (30)